T J Schroeder

461 total citations
45 papers, 354 citations indexed

About

T J Schroeder is a scholar working on Transplantation, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, T J Schroeder has authored 45 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Transplantation, 21 papers in Surgery and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in T J Schroeder's work include Renal Transplantation Outcomes and Treatments (24 papers), Organ Transplantation Techniques and Outcomes (14 papers) and Pharmacological Effects and Toxicity Studies (9 papers). T J Schroeder is often cited by papers focused on Renal Transplantation Outcomes and Treatments (24 papers), Organ Transplantation Techniques and Outcomes (14 papers) and Pharmacological Effects and Toxicity Studies (9 papers). T J Schroeder collaborates with scholars based in United States. T J Schroeder's co-authors include M. Roy First, Sundaram Hariharan, V.R. Peddi, Ritschel Wa, Tito Cavallo, Malay B. Shah, William F. Balistreri, R Munda, Jill Martin and P Weiskittel and has published in prestigious journals such as Clinical Chemistry, Transplantation and Therapeutic Drug Monitoring.

In The Last Decade

T J Schroeder

44 papers receiving 325 citations

Peers

Countries citing papers authored by T J Schroeder

Since Specialization

Citations

This map shows the geographic impact of T J Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T J Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T J Schroeder more than expected).

Fields of papers citing papers by T J Schroeder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T J Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T J Schroeder. The network helps show where T J Schroeder may publish in the future.

Co-authorship network of co-authors of T J Schroeder

This figure shows the co-authorship network connecting the top 25 collaborators of T J Schroeder. A scholar is included among the top collaborators of T J Schroeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T J Schroeder. T J Schroeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P-211 Splicing gene mutations in MDS and secondary AML: Clinical implications in the setting of allogeneic hematopoietic stem cell transplantation 2013 ·Leukemia Research ·Felicitas Thol, Christian Koenecke, (unknown), Sofia Kade, Lily Huang, Uwe Platzbecker, Christian Thiede, T J Schroeder, Guido Kobbe, (unknown), Gudrun Göhring, Elke Dammann, (unknown), (unknown), Michael Hallensleben, Brigitte Schlegelberger, J. Krauter, Arnold Ganser, Nicolaus Kröger, Michael Heuser	2
2	Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients 1999 ·Transplantation Proceedings ·Robert A. Fisher, (unknown), Sandra Rossi, T J Schroeder, William Irish, D. M. Canafax, (unknown)	6
3	Validity of open labeled versus blinded trials: a meta–analysis comparing neoral and sandimmune 1999 ·Transplantation Proceedings ·Malay B. Shah, Jill Martin, T J Schroeder, M. Roy First	2
4	Can Anti-HLA Antibody Analyses Postcardiac Transplantation Predict Acute Allograft Rejection and Survival? 1998 ·Transplantation Proceedings ·Geetha Bhat, T J Schroeder, Kamala Balakrishnan	6
5	A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: sandimmune and neoral 1998 ·Transplantation Proceedings ·Malay B. Shah, Jill Martin, T J Schroeder, M. Roy First	6
6	Evaluation of the safety and tolerability of neoral and sandimmune: a meta-analysis 1998 ·Transplantation Proceedings ·Malay B. Shah, Jill Martin, T J Schroeder, M. Roy First	6
7	The Cost of Rejection in Liver Allograft Recipients 1998 ·Transplantation Proceedings ·Jill Martin, P. Fleck, T J Schroeder, J Whiting, Douglas W. Hanto	8
8	A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus 1998 ·Transplantation Proceedings ·(unknown), T J Schroeder, Malay B. Shah, Sundaram Hariharan, V.R. Peddi, P Weiskittel, M. Roy First	11
9	Tacrolimus use in kidney–pancreas recipients is associated with less acute renal dysfunction than cyclosporine 1998 ·Transplantation Proceedings ·P. Fleck, T J Schroeder, (unknown), V.R. Peddi, M. Roy First	1
10	Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral. 1998 ·PubMed ·M. Roy First, (unknown), T J Schroeder	20
11	Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients 1997 ·Transplantation Proceedings ·(unknown), Sundaram Hariharan, V.R. Peddi, R Munda, T J Schroeder, (unknown), J. Wesley Alexander, M. Roy First	11
12	Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation 1997 ·Transplantation Proceedings ·Sundaram Hariharan, V.R. Peddi, R Munda, (unknown), T J Schroeder, J. Wesley Alexander, M. Roy First	11
13	A generic cyclosporine development program 1997 ·Transplantation Proceedings ·T J Schroeder, (unknown), Philippe Pouletty, M. Roy First	3
14	Increased resources are required in patients with low cyclosporine bioavailability. 1996 ·PubMed ·T J Schroeder, Malay B. Shah, S. Hariharan, M. Roy First	6
15	Serial monitoring of soluble interleukin-2 receptor as a rapid marker of cytomegalovirus infection and response to antiviral therapy. 1996 ·PubMed ·Stephen J. Rossi, T J Schroeder, K Muth, Douglas W. Hanto, R Munda, S. Hariharan, First Mr, Frederick Ryckman, William F. Balistreri	5
16	Reduction of the initial febrile response to OKT3 with indomethacin. 1993 ·PubMed ·M. Roy First, T J Schroeder, Sundaram Hariharan, P Weiskittel	5
17	Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial. 1993 ·PubMed ·M. Roy First, T J Schroeder, (unknown), Sundaram Hariharan, P Weiskittel, (unknown)	11
18	Monitoring of OKT3(R) Serum Concentrations Using a Cartridge-Based Enzyme Immunoassay System 1993 ·Therapeutic Drug Monitoring ·(unknown), (unknown), T J Schroeder, Philippe Pouletty	1
19	Effect of race on transplant outcome and response to OKT3 monoclonal antibody therapy. 1989 ·PubMed ·M. Roy First, T J Schroeder, Michelle A. Carey, (unknown)	7
20	Use of cyclosporine by constant-rate intravenous infusion immediately after heart transplantation. 1988 ·PubMed ·Steven A. Myre, T J Schroeder, David Melvin, Christopher Clardy, Alessandro Pesce, Nand K. Wadhwa, Jannette Collins, Randall K. Wolf, Lucy L. Brown, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact